Oticon More vs Resound Vivia 9 60S microRIE

The Oticon More is a premium behind-the-ear prescription hearing aid that earned an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 22% of the 36 prescription hearing aids we've evaluated. Released in 2021, this device remains competitive and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrated strong speech clarity performance. Speech in quiet scored 4.0/5, which is 0.73 points above the category average—a notable margin that reflects genuine audibility advantages in everyday conversations. Speech in noise measured 2.7/5, which is above the category average by 0.75 points, though only mixed in absolute terms, meaning challenging listening environments may still require effort. Own-voice comfort scored a solid 3.1/5 (+0.35 vs category average), and music streaming measured 3.0/5 (+0.36 vs category average), both performing above typical prescription aids. Feedback handling scored 3.5/5, which is solid in absolute terms, though below the category average of 4.71/5 by 1.21 points—something to discuss with your hearing care provider. At $4,598, this is a premium-priced device offering iPhone and Android streaming, hands-free calling, and your choice of rechargeable or disposable batteries. The Oticon More is well-suited for those prioritizing speech clarity who want a proven performer from an established manufacturer. Competitors in this price range include the newer Oticon Intent (4.85/5) and Oticon Real (4.75/5), which may be worth comparing during your fitting appointment.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.